The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Biodegradable polymeric nanoparticles based drug delivery systems
Open accessAbstract
Biodegradable nanoparticles have been used frequently as drug delivery vehicles due to its grand bioavailability, better encapsulation, control release and less toxic properties. Various nanoparticulate systems, general synthesis and encapsulation process, control release and improvement of therapeutic value of nanoencapsulated drugs are covered in this review. We have highlighted the impact of nanoencapsulation of various disease related drugs on biodegradable nanoparticles such as PLGA, PLA, chitosan, gelatin, polycaprolactone and poly-alkyl-cyanoacrylates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Encyclopedia of Nanoscience and Nanotechnology
(2013) · Chemical & Engineering News Archive · doi:10.1021/cen-09136-ad11 · Cited by 2,546
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.014 · Cited by 2,334
Nanocapsule formation by interfacial polymer deposition following solvent displacement
Fessi, H., Puisieux, F., Devissaguet, J. P., Ammoury, N., & Benita, S. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90281-0 · Cited by 2,288
Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers
Calvo, P., Remu��n-L�pez, C., Vila-Jato, J. L., & Alonso, M. J. (1997) · Journal of Applied Polymer Science · doi:10.1002/(sici)1097-4628(19970103)63:1<125::aid-app13>3.0.co;2-4 · Cited by 1,856
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles
Pinto Reis, C., Neufeld, R. J., Ribeiro, & Veiga, F. (2006) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2005.12.003 · Cited by 1,354
Biodegradable nanoparticles for drug delivery and targeting
Hans, M. L., & Lowman, A. M. (2002) · Current Opinion in Solid State and Materials Science · doi:10.1016/s1359-0286(02)00117-1 · Cited by 1,324
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.013 · Cited by 1,305
TORCHILIN, V (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.009 · Cited by 1,273
Panyam, J., Zhou, W., Prabha, S., Sahoo, S. K., & Labhasetwar, V. (2002) · The FASEB Journal · doi:10.1096/fj.02-0088com · Cited by 1,044
Mundargi, R. C., Babu, V. R., Rangaswamy, V., Patel, P., & Aminabhavi, T. M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.09.013 · Cited by 1,025
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
Storm, G., Belliot, S. O., Daemen, T., & Lasic, D. D. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00039-a · Cited by 877
Fonseca, C., Simões, S., & Gaspar, R. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00212-2 · Cited by 755
Mu, L., & Feng, S. S. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00320-6 · Cited by 725
Chitosan nanoparticles as delivery systems for doxorubicin
Janes, K. A., Fresneau, M. P., Marazuela, A., Fabra, A., & Alonso, M. J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00294-2 · Cited by 721
Long circulating microparticulate drug carriers
Stolnik, S., Illum, L., & Davis, S. S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00025-3 · Cited by 700
Pan, Y., Li, Y.-J., Zhao, H.-Y., Zheng, J.-M., Xu, H., Wei, G., Hao, J.-S., & Cui, F.-D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00486-6 · Cited by 686
De Campos, A. M., Sánchez, A., & Alonso, M. J. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00760-8 · Cited by 666
Poly(ethylene glycol)-modified Nanocarriers for Tumor-targeted and Intracellular Delivery
van Vlerken, L. E., Vyas, T. K., & Amiji, M. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9284-6 · Cited by 645
Safra, T., Muggia, F., Jeffers, S., Tsao-Wei, D. D., Groshen, S., Lyass, O., Henderson, R., Berry, G., & Gabizon, A. (2000) · Annals of Oncology · doi:10.1023/a:1008365716693 · Cited by 618
Alginate/Chitosan Nanoparticles are Effective for Oral Insulin Delivery
Sarmento, B., Ribeiro, A., Veiga, F., Sampaio, P., Neufeld, R., & Ferreira, D. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9367-4 · Cited by 617
Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation
Danhier, F., Lecouturier, N., Vroman, B., Jérôme, C., Marchand-Brynaert, J., Feron, O., & Préat, V. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.086 · Cited by 616
Nanocapsule Technology: A Review
Couvreur, P., Barratt, G., Fattal, E., & Vauthier, C. (2002) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v19.i2.10 · Cited by 555
Mittal, G., Sahana, D. K., Bhardwaj, V., & Ravi Kumar, M. N. V. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.01.016 · Cited by 551
Lee, K. S., Chung, H. C., Im, S. A., Park, Y. H., Kim, C. S., Kim, S.-B., Rha, S. Y., Lee, M. Y., & Ro, J. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9591-y · Cited by 541
Barichello, J. M., Morishita, M., Takayama, K., & Nagai, T. (1999) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-100102197 · Cited by 539
Erbacher, P., Zou, S., Bettinger, T., Steffan, A.-M., & Remy, J.-S. (1998) · Pharmaceutical Research · doi:10.1023/a:1011981000671 · Cited by 536
Plastic-Compatible Low Resistance Printable Gold Nanoparticle Conductors for Flexible Electronics
Huang, D., Liao, F., Molesa, S., Redinger, D., & Subramanian, V. (2003) · Journal of The Electrochemical Society · doi:10.1149/1.1582466 · Cited by 524
Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles
Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. S., Kivman, G. Y., & Kreuter, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018983904537 · Cited by 521
Charles F. Kettring prize. Fundamental studies with cisplatin
Rosenberg, B. (1985) · Cancer · doi:10.1002/1097-0142(19850515)55:10<2303::aid-cncr2820551002>3.0.co;2-l · Cited by 517
Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate
Wu, Y., Yang, W., Wang, C., Hu, J., & Fu, S. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.042 · Cited by 517
Avgoustakis, K. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00530-2 · Cited by 503
Which polymers can make nanoparticulate drug carriers long-circulating?
Torchilin, V. P., & Trubetskoy, V. S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00022-y · Cited by 480
Colloidal Drug Delivery Systems
Kreuter, J. (2014) · CRC Press eBooks · doi:10.1201/9781498710565 · Cited by 469
Perelshtein, I., Applerot, G., Perkas, N., Guibert, G., Mikhailov, S., & Gedanken, A. (2008) · Nanotechnology · doi:10.1088/0957-4484/19/24/245705 · Cited by 440
Redhead, H. M., Davis, S. S., & Illum, L. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00367-9 · Cited by 419
Colloidal drug delivery systems
Duncan-Hewitt, W. C. (1995) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/0927-7765(95)90010-1 · Cited by 419
Tobı́o, M., Sánchez, A., Vila, A., Soriano, I., Evora, C., Vila-Jato, J. L., & Alonso, M. J. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00157-5 · Cited by 368
Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats
Damgé, C., Maincent, P., & Ubrich, N. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.023 · Cited by 351
CHITOSAN NANOPARTICLES: A PROMISING SYSTEM FOR DRUG DELIVERY
Tiyaboonchai, W. (2003) · Asian Health, Science and Technology Reports · Cited by 341
Shenoy, D. B., & Amiji, M. M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.12.010 · Cited by 331
Levitzki, A. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.14.1426765 · Cited by 317
Protein nanoparticle: A unique system as drug delivery vehicles
Jahanshahi, M., & Babaei, Z. (2008) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.4314/ajb.v7i25.59701 · Cited by 314
Nanomedicines for overcoming biological barriers
José Alonso, M. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.01.007 · Cited by 312
Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles☆
DATE, A., JOSHI, M., & PATRAVALE, V (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.009 · Cited by 293
A Novel Approach to the Oral Delivery of Micro- or Nanoparticles
Bodmeier, R., Chen, H., & Paeratakul, O. (1989) · Pharmaceutical Research · doi:10.1023/a:1015987516796 · Cited by 276
Nanoparticle Technology for Delivery of Drugs Across the Blood–Brain Barrier
Schroeder, U., Sommerfeld, P., Ulrich, S., & Sabel, B. A. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980084y · Cited by 275
Leroux, J.-C., Allémann, E., De Jaeghere, F., Doelker, E., & Gurny, R. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00164-6 · Cited by 268
Lai, F., Wissing, S. A., Müller, R. H., & Fadda, A. M. (2006) · AAPS PharmSciTech · doi:10.1208/pt070102 · Cited by 266
Sahana, D. K., Mittal, G., Bhardwaj, V., & Kumar, M. N. V. R. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21158 · Cited by 260
Encapsulation of dexamethasone into biodegradable polymeric nanoparticles
GOMEZGAETE, C., TSAPIS, N., BESNARD, M., BOCHOT, A., & FATTAL, E. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.11.028 · Cited by 259
Paclitaxel-Loaded Gelatin Nanoparticles for Intravesical Bladder Cancer Therapy
Lu, Z., Yeh, T.-K., Tsai, M., Au, J. L.-S., & Wientjes, M. G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1443 · Cited by 256
Ahmad, Z., Pandey, R., Sharma, S., & Khuller, G. K. (2006) · PubMed · Cited by 231
Alyautdin, R. N., Tezikov, E. B., Ramge, P., Kharkevich, D. A., Begley, D. J., & Kreuter, J. (1998) · Journal of Microencapsulation · doi:10.3109/02652049809006836 · Cited by 229
Kim, S. Y., & Lee, Y. M. (2001) · Biomaterials · doi:10.1016/s0142-9612(00)00292-1 · Cited by 227
Kawashima, Y., Yamamoto, H., Takeuchi, H., & Kuno, Y. (2000) · Pharmaceutical Development and Technology · doi:10.1081/pdt-100100522 · Cited by 215
Nanoparticles of biodegradable polymers for new-concept chemotherapy
Feng, S.-S. (2004) · Expert Review of Medical Devices · doi:10.1586/17434440.1.1.115 · Cited by 206
Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA–PEG–folate conjugate
Esmaeili, F., Ghahremani, M. H., Ostad, S. N., Atyabi, F., Seyedabadi, M., Malekshahi, M. R., Amini, M., & Dinarvand, R. (2008) · Journal of Drug Targeting · doi:10.1080/10611860802088630 · Cited by 203
Potineni, A., Lynn, D. M., Langer, R., & Amiji, M. M. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00374-7 · Cited by 201
Preparation and characterization of protein C-loaded PLA nanoparticles
Zambaux, M. F., Bonneaux, F., Gref, R., Dellacherie, E., & Vigneron, C. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00073-5 · Cited by 200
Derakhshandeh, K., Erfan, M., & Dadashzadeh, S. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.09.004 · Cited by 200
Metal-containing nanoparticles and nano-structured particles in fingermark detection
Choi, M. J., McDonagh, A. M., Maynard, P., & Roux, C. (2008) · Forensic Science International · doi:10.1016/j.forsciint.2008.04.027 · Cited by 199
Kreuter, J., Petrov, V. E., Kharkevich, D. A., & Alyautdin, R. N. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00061-8 · Cited by 196
Arterial Uptake of Biodegradable Nanoparticles: Effect of Surface Modifications
Labhasetwar, V., Song, C., Humphrey, W., Shebuski, R., & Levy, R. J. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980021f · Cited by 190
Teixeira, M., Alonso, M. J., Pinto, M. M. M., & Barbosa, C. M. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.09.002 · Cited by 188
Carrasquillo, K. G., Stanley, A. M., Aponte-Carro, J. C., De Jésus, P., Costantino, H. R., Bosques, C. J., & Griebenow, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00430-8 · Cited by 181
Bender, A. R., von Briesen, H., Kreuter, J., Duncan, I. B. R., & Rübsamen‐Waigmann, H. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.6.1467 · Cited by 177
Hedberg, E. L., Shih, C. K., Lemoine, J. J., Timmer, M. D., K. Liebschner, M. A., Jansen, J. A., & Mikos, A. G. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.09.012 · Cited by 173
Choi, C., Chae, S. Y., & Nah, J.-W. (2006) · Polymer · doi:10.1016/j.polymer.2006.05.011 · Cited by 169
Chitosan-dextran Sulfate Nanoparticles for Delivery of an Anti-angiogenesis Peptide
Chen, Y., Mohanraj, V. J., & Parkin, J. E. (2003) · International Journal of Peptide Research and Therapeutics · doi:10.1007/bf02442596 · Cited by 166
Design of gelatin nanoparticles as swelling controlled delivery system for chloroquine phosphate
Bajpai, A. K., & Choubey, J. (2006) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-006-8235-9 · Cited by 161
Sheng, Y., Yuan, Y., Liu, C., Tao, X., Shan, X., & Xu, F. L. (2009) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-009-3746-9 · Cited by 159
Intracellular Delivery of Saquinavir in Biodegradable Polymeric Nanoparticles for HIV/AIDS
Shah, L. K., & Amiji, M. M. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9101-7 · Cited by 155
Ikezoe, T., Yang, Y., Bandobashi, K., Saito, T., Takemoto, S., Machida, H., Togitani, K., Koeffler, H. P., & Taguchi, H. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0277 · Cited by 154
Johansen, P., Men, Y., Audran, R., Corradin, G., Merkle, H. P., & Gander, B. A. (1998) · Pharmaceutical Research · doi:10.1023/a:1011998615267 · Cited by 153
Design of nanoparticles of less than 50 nm diameter: preparation, characterization and drug loading
Seijo, B., Fattal, E., Roblot-Treupel, L., & Couvreur, P. (1990) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(90)90024-x · Cited by 151
Chitosan and lactic acid-grafted chitosan nanoparticles as carriers for prolonged drug delivery
Bhattarai, N., Ramay, H. R., Chou, S.-H. S., & Zhang, M. (2006) · International Journal of Nanomedicine · doi:10.2147/nano.2006.1.2.181 · Cited by 141
Sonaje, K., Italia, J. L., Sharma, G., Bhardwaj, V., Tikoo, K., & Kumar, M. N. V. R. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9207-y · Cited by 140
Raghuvanshi, R. S., Katare, Y. K., Lalwani, K., Ali, M. M., Singh, O., & Panda, A. K. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00342-3 · Cited by 140
PEGylated polycyanoacrylate nanoparticles as vector for drug delivery in prion diseases
Calvo, P., Gouritin, B., Brigger, I., Lasmézas, C. I., Deslys, J., Williams, A., Andreux, J. P., Dormont, D., & Couvreur, P. (2001) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(01)00450-2 · Cited by 138
Matsumoto, J., Nakada, Y., Sakurai, K., Nakamura, T., & Takahashi, Y. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00153-2 · Cited by 137
Patil, S. D., Papadimitrakopoulos, F., & Burgess, D. J. (2004) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2004.6.887 · Cited by 135
Pectin/poly(lactide-co-glycolide) composite matrices for biomedical applications
Liu, L., Won, Y. J., Cooke, P. H., Coffin, D. R., Fishman, M. L., Hicks, K. B., & Ma, P. X. (2003) · Biomaterials · doi:10.1016/j.biomaterials.2003.10.036 · Cited by 125
Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin™ for active targeting
Bossy-Nobs, L., Buchegger, F., Gurny, R., & Allémann, É. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.04.006 · Cited by 117
Kaur, A., Jain, S. K., & Tiwary, A. K. (2008) · Acta Pharmaceutica · doi:10.2478/v10007-007-0045-1 · Cited by 116
Wang, Y. M., Sato, H., Adachi, I., & Horikoshi, I. (1996) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.44.1935 · Cited by 113
Lee, S. H., Zhang, Z., & Feng, S. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.01.003 · Cited by 112
Leo, E., Brina, B., Forni, F., & Vandelli, M. A. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.03.002 · Cited by 111
Yin, Y.-S., Chen, D., Qiao, M., Wei, X., & Hu, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.06.024 · Cited by 109
Rodrigues, J. S., Santos-Magalhães, N. S., Coelho, L. C. B. B., Couvreur, P., Ponchel, G., & Gref, R. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00296-7 · Cited by 107
Gelatin nanoencapsulation of protein/peptide drugs using an emulsifier-free emulsion method
Li†, J. K., Wang, N., & Wu, X. S. (1998) · Journal of Microencapsulation · doi:10.3109/02652049809006846 · Cited by 107
GAO, H., WANG, Y., FAN, Y., & MA, J. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.06.010 · Cited by 106
Borchard, G., Audus, K. L., Shi, F., & Kreuter, J. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90372-7 · Cited by 105
Hedberg, E. L., Kroese‐Deutman, H. C., Shih, C. K., Crowther, R. S., Carney, D. H., Mikos, A. G., & Jansen, J. A. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.11.039 · Cited by 104
Solid colloidal drug delivery systems: Nanoparticles
Oppenheim, R. C. (1981) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(81)90100-9 · Cited by 102
Studies on the oridonin-loaded poly(d,l-lactic acid) nanoparticles in vitro and in vivo
Xing, J., Zhang, D., & Tan, T. (2007) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2006.07.001 · Cited by 99
Mainardes, R. M., Gremião, M. P. D., Brunetti, I. L., da Fonseca, L. M., & Khalil, N. M. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21406 · Cited by 96
Cationic Poly(lactide-co-glycolide) Nanoparticles as Efficient in vivo Gene Transfection Agents
Kumar, M. N. V. R., Mohapatra, S. S., Kong, X., Jena, P. K., Bakowsky, U., & Lehr, C. (2004) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2004.130 · Cited by 94
Nanoparticulate delivery system of a tyrphostin for the treatment of restenosis
Fishbein, I., Chorny, M., Rabinovich, L., Banai, S., Gati, I., & Golomb, G. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00244-8 · Cited by 89
Miyazaki, S., Takahashi, A., Kubo, W., BACHYNSKY, J. A., & Löebenberg, R. (2003) · PubMed · Cited by 73
Toro, R. D., Betti, V., & Spampinato, S. M. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2003.10.001 · Cited by 69
Design of triptorelin loaded nanospheres for transdermal iontophoretic administration
Nicoli, S., Santi, P., Couvreur, P., Couarraze, G., Colombo, P., & Fattal, E. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00632-3 · Cited by 67
Study on docetaxel-loaded nanoparticles with high antitumor efficacy against malignant melanoma
Zheng, D., Li, X., Xu, H., Lu, X., Hu, Y., & Fan, W. (2009) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmp045 · Cited by 67
Physico-chemical characterization of polysaccharide-coated nanoparticles
Lemarchand, C., Gref, R., Lesieur, S., Hommel, H., Vacher, B., Besheer, A., Mäder, K., & Couvreur, P. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.07.014 · Cited by 63
Cheng, Q., Feng, J., Chen, J., Zhu, X., & Li, F. (2008) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.621 · Cited by 53
Bittner, B., Ronneberger, B., Zange, R., Volland, C., Anderson, J. M., & Kissel, T. (1998) · Journal of Microencapsulation · doi:10.3109/02652049809006876 · Cited by 51
Prabu, P., Chaudhari, A. A., Dharmaraj, N., Khil, M., Park, S. Y., & Kim, H. Y. (2008) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32163 · Cited by 49
Kumar, K. S., Ramakrishna, S., Saini, T. R., et al. (2006) · PubMed · Cited by 43
Bajpai, A. K., & Choubey, J. (2005) · Journal of Macromolecular Science Part A · doi:10.1081/ma-200050357 · Cited by 42
Studies with glycyrrhetic acid: inhibition of metabolism of steroids in vitro
Atherden, L. M. (1958) · Biochemical Journal · doi:10.1042/bj0690075 · Cited by 35
Wang, L., Chaw, C. S., Yang, Y. Y., Moochhala, S., Zhao, B., Ng, S., & Heller, J. (2003) · Biomaterials · doi:10.1016/j.biomaterials.2003.09.099 · Cited by 35
Gürsoy, A., Eroǧlu, L., Balkuv-Ulutin, Ş., Tasyurek, H. M., Fessi, H., Puisieux, F., & Devissaguet, J. P. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90283-4 · Cited by 30
Simple preparation of nanoparticles coated with carbohydrate-carrying polymers
Cho, C. S., Jeong, Y., Ishihara, T., Takei, R., Park, J. U., Park, K. H., Maruyama, A., & Akaike, T. (1997) · Biomaterials · doi:10.1016/s0142-9612(96)00138-x · Cited by 28
Fassas, Α., Buffels, R., Kaloyannidis, P., & Anagnostopoulos, Α. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04395_3.x · Cited by 27
Bonduelle, S., Foucher, C., Leroux, J., Chouinard, F., Cadieux, C., & Lenaerts, V. (1991) · Journal of Microencapsulation · doi:10.3109/02652049109021233 · Cited by 23
Cellular uptake and radiosensitization of SR-2508 loaded PLGA nanoparticles
Jin, C. S., Bai, L., Wu, H., Teng, Z., Guo, G., & Chen, J. (2007) · Journal of Nanoparticle Research · doi:10.1007/s11051-007-9336-1 · Cited by 14
Volz, H., Möller, H., Gerebtzoff, A., & Bischoff, S. F. (2002) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-002-0364-7 · Cited by 3
Cited by
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Nanoparticles as drug delivery systems
Wilczewska, A. Z., Niemirowicz, K., Markiewicz, K. H., & Car, H. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70901-5 · Cited by 1,445
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
Acharya, S., & Sahoo, S. K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.10.008 · Cited by 1,112
The Smart Drug Delivery System and Its Clinical Potential
Liu, D., Yang, F., Xiong, F., & Gu, N. (2016) · Theranostics · doi:10.7150/thno.14858 · Cited by 1,066
Metadata
- Authors
- Kumari, A., Yadav, S. K., & Yadav, S. C.
- Venue
- Colloids and Surfaces B: Biointerfaces
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 75
- Issue
- 1
- Pages
- 1-18
- ISSN
- 0927-7765 (ISSN-L)
- OpenAlex
- W2066685510
- Cited by
- 3,724
- References
- 121
- FWCI
- 35.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.